Histological grade predicts for recurrence in patients with uterine endometrioid carcinoma without myometrial involvement

Anticancer Research

Volumn 32, Issue 9, 2012, Pages 4061-4065

  Zaki, Mark A ^a   Robbins, Jared R ^a   Fatteh, Saif ^a   Mahan, Meredith G ^a   Hanna, Rabbie K ^a   Elshaikh, Mohamed A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Endometrial carcinoma; FIGO stage IA; Myometrial invasion; Prognosis; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; ENDOMETRIOID CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE FREE SURVIVAL; RECURRENT CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; MYOMETRIUM; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 84867017891     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Siegel R, Naishadham D and Jemal A: Cancer Statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
2. Fung-Kee-Fung M, Dodge J, Elit L, Lukka H, Chambers A and Oliver T: Follow-up after primary therapy for endometrial cancer: A systemic review. Gynecologic Oncology 101: 520-529, 2006.
3. ASTEC/EN.5 Study Group, Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, Eisenhauer E, Bacon M, Tu D, Parmar MK, Amos C, Murray C and Qian W: Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomized trials): Pooled trial results, systematic review, and meta-analysis. Lancet 373: 137-146, 2009.
4. Signorelli M, Lissoni AA, Cormio G, Katsaros D, Pellegrino A, Selvaggi L, Ghezzi F, Scambia G, Zola P, Grassi R, Milani R, Giannice R, Caspani G, Mangioni C, Floriani I, Rulli E and Fossati R: Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study. Ann Surg Oncol 16: 3431-3441, 2009.
5. Esselen KM, Boruta DM, del Carmen M, Schorge JO, Goodman A and Growdon WB: Defining prognostic variables in recurrent endometrioid endometrial cancer: A 15-year single-institution review. Int J Gynecol Cancer 21: 1078-1083, 2011.
6. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spiritos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG; and Gynecologic Oncology Group: A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 92: 744-751, 2004.
7. Scholten AN, van Putten WL, Beerman H, Smit VT, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, De Winter KE, Lutgens LC, van Lent M, Creutzberg CL; and PORTEC Study Group: Postoperative radiotherapy for stage I endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 63: 834-838, 2005.
8. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY and Pecorelli S: Carcinoma of the corpus uteri. FIGO 26th Annual Report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1): S105-43, 2006.
9. Salani R, Nagel C, Drennen E and Bristow RE: Recurrence patterns and surveillance for patients with early stage endometrial cancer. Gynecol Oncol 123: 205-207, 2011.
10. Rasool N, Fader AN, Seamon L, Neubauer NL, Shahin FA, Alexander HA, Moore K, Secord AA, Kunos C, Rose PG and O'Malley DM: Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence. Gynecol Oncol 116: 10-14, 2010.
11. Straugn JM Jr, Huh WK, Kelly FJ, Learh CA 3rd, Kleinberg MJ, Hyde J Jr., Numnum TM, Zhang Y, Soong SJ, Austin JM Jr., Partridge EE, Kilgore LC and Alvarez RD: Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 84: 194-200, 2002.
12. Konski A, Domenico D, Tyrkus M, Irving D, Neisler J, Phibbs G, Zeidner S and Eggleston W: Prognostic characteristics of surgical stage I endometrial adenocarcinoma. Int J Radiat Oncol Biol Phys 35: 935-940, 1996.
13. Abu-Rustum NR, Zhou Q, Iasonos A, Alektiar KM, Leitao MM Jr., Chi DS, Sonoda Y, Soslow R, Hensley M and Barakat RR: The revised 2009 FIGO staging system for endometrial cancer: Should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer 21: 511-516, 2011.
14. Grigsby PW, Perez CA, Kuten A, Simpson JR, Garcia DM, Camel HM, Kao MS and Galakatos AE: Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys 22: 905-911, 1992.
15. Fujimoto T, Nanjyo H, Fukuda J, Nakamura A, Mizunuma H, Yaegashi N, Sugiyama T, Kurachi H, Sato A and Tanaka T: Endometrioid uterine cancer: Histopathological risk factors of local and distant recurrence. Gynecol Oncol 112: 342-347, 2009.
16. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, van den Bergh AC, de Winter KA, Koper PC, Lybeert ML, Slot A, Lutgens LC, Stenfert Kroese MC, Beerman H, van Lent M; and postoperative Radiation Therapy in Endometrial Carcinoma Trial: Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: The postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol 22: 1234-1241, 2004.
17. Abu-Rustum NR, Zhou Q, Gomez JD, Alektiar KM, Hensley ML, Soslow RA, Levine DA, Chi DS, Barakat RR and Iasonos A: A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: Toward improving individualized cancer care. Gynecol Oncol 116: 399-403, 2010.
18. Querleu D, Planchamp F, Narducci F, Joly F, Genestie C, Haie-Meder C, Thomas L, Quenel-Tueux N, Darai E, Dorangeon PH, Marret H Taieb S, Mazeau-Woynar V; Institut National du Cancer; and Societe Francaise d'Oncologie Gynecologique: Clinical practice guidelines for the management of patients with endometrial cancer in France. Recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gyné cologique. Int J Gynecol Cancer 21: 945-950, 2011.
19. Gynecologic Oncology Group (GOG) study 0249 Protocol. Available at: https://www.ctsu.org/public/data/protocols/GOG/GOG-0249/schema.pdf. Last accessed April 2, 2012.